Literature DB >> 19851334

Building ubiquitin chains: E2 enzymes at work.

Yihong Ye1, Michael Rape.   

Abstract

The modification of proteins with ubiquitin chains can change their localization, activity and/or stability. Although ubiquitylation requires the concerted action of ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s), it is the E2s that have recently emerged as key mediators of chain assembly. These enzymes are able to govern the switch from ubiquitin chain initiation to elongation, regulate the processivity of chain formation and establish the topology of assembled chains, thereby determining the consequences of ubiquitylation for the modified proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851334      PMCID: PMC3107738          DOI: 10.1038/nrm2780

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  95 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

Authors:  Richard Baer; Thomas Ludwig
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

3.  Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer.

Authors:  A P VanDemark; R M Hofmann; C Tsui; C M Pickart; C Wolberger
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

4.  Structural and functional analysis of the human mitotic-specific ubiquitin-conjugating enzyme, UbcH10.

Authors:  Yaqiong Lin; William C Hwang; Ravi Basavappa
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

5.  A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins.

Authors:  Simona Polo; Sara Sigismund; Mario Faretta; Monica Guidi; Maria Rosaria Capua; Giovanna Bossi; Hong Chen; Pietro De Camilli; Pier Paolo Di Fiore
Journal:  Nature       Date:  2002-03-28       Impact factor: 49.962

6.  Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

Authors:  N Zheng; P Wang; P D Jeffrey; N P Pavletich
Journal:  Cell       Date:  2000-08-18       Impact factor: 41.582

7.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.

Authors:  Carsten Hoege; Boris Pfander; George-Lucian Moldovan; George Pyrowolakis; Stefan Jentsch
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

8.  The human RAD18 gene product interacts with HHR6A and HHR6B.

Authors:  H Xin; W Lin; W Sumanasekera; Y Zhang; X Wu; Z Wang
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

9.  Identification of molecular determinants required for interaction of ubiquitin-conjugating enzymes and RING finger proteins.

Authors:  G Martinez-Noel; U Müller; K Harbers
Journal:  Eur J Biochem       Date:  2001-11

10.  The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.

Authors:  S Fang; M Ferrone; C Yang; J P Jensen; S Tiwari; A M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

View more
  419 in total

1.  Rad8Rad5/Mms2-Ubc13 ubiquitin ligase complex controls translesion synthesis in fission yeast.

Authors:  Stéphane Coulon; Sharada Ramasubramanyan; Carole Alies; Gaëlle Philippin; Alan Lehmann; Robert P Fuchs
Journal:  EMBO J       Date:  2010-05-07       Impact factor: 11.598

2.  Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.

Authors:  Gozde Kar; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Proteome Res       Date:  2012-01-10       Impact factor: 4.466

3.  Protein-linked ubiquitin chain structure restricts activity of deubiquitinating enzymes.

Authors:  Jonathan B Schaefer; David O Morgan
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

4.  E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.

Authors:  Sarah E Soss; Yuanyuan Yue; Sirano Dhe-Paganon; Walter J Chazin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

5.  Insights into ubiquitin-conjugating enzyme/ co-activator interactions from the structure of the Pex4p:Pex22p complex.

Authors:  Chris Williams; Marlene van den Berg; Santosh Panjikar; Will A Stanley; Ben Distel; Matthias Wilmanns
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

Review 6.  Regulation of Parkin E3 ubiquitin ligase activity.

Authors:  Helen Walden; R Julio Martinez-Torres
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 7.  Shaping the landscape: mechanistic consequences of ubiquitin modification of chromatin.

Authors:  Sigurd Braun; Hiten D Madhani
Journal:  EMBO Rep       Date:  2012-06-29       Impact factor: 8.807

Review 8.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

9.  The Anaphase-Promoting Complex (APC) ubiquitin ligase regulates GABA transmission at the C. elegans neuromuscular junction.

Authors:  Jennifer R Kowalski; Hitesh Dube; Denis Touroutine; Kristen M Rush; Patricia R Goodwin; Marc Carozza; Zachary Didier; Michael M Francis; Peter Juo
Journal:  Mol Cell Neurosci       Date:  2013-12-07       Impact factor: 4.314

10.  Exploring the Functional Consequences of Protein Backbone Alteration in Ubiquitin through Native Chemical Ligation.

Authors:  Halina M Werner; Samuel K Estabrooks; G Michael Preston; Jeffrey L Brodsky; W Seth Horne
Journal:  Chembiochem       Date:  2019-08-23       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.